Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Parkinson's disease (PD), a common neurodegenerative disorder ... If we are able to complete drug screening among these subgroups, a list of customised drugs suitable for the patient's genotype can be ...

At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...

Create a medication list, which your doctor and pharmacist can help you fill out. It’s also important to read the label of Ozempic and other paperwork that may come with the drug. The label may ...

Several drug classes are commonly used to treat MDD, including antidepressants, antipsychotics, anti-anxiety medications, and other types of mood-stabilizing drugs. This variety of classes can help ...